Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial

This randomized clinical trial (Registration: NCT03085134) assessed if an extensively hydrolyzed formula (EHF) supplemented with two human milk oligosaccharides (HMO) and reduced protein content (2.20 g/100 kcal) supports normal growth in infants with cow’s milk protein allergy (CMPA). Secondary out...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandenplas, Yvan, Żołnowska, Marta, Berni Canani, Roberto, Ludman, Siân, Tengelyi, Zsuzsanna, Moreno-Álvarez, Ana, Goh, Anne E. N., Gosoniu, Maria Laura, Kirwan, Bridget-Anne, Tadi, Monika, Heine, Ralf G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839689/
https://www.ncbi.nlm.nih.gov/pubmed/35276889
http://dx.doi.org/10.3390/nu14030530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839689/
https://www.ncbi.nlm.nih.gov/pubmed/35276889
http://dx.doi.org/10.3390/nu14030530

Ejemplares similares